Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | Suppliers

Enamine - Small Molecule Compound Libraries, Diversity/Focus Sets, Fragments, Custom Synthesis from Integrated Hit Finding to Lead Optimization in Drug Discovery Under Flexible Business Models White Papers

Enamine - Small Molecule Compound Libraries, Diversity/Focus Sets, Fragments, Custom Synthesis from Integrated Hit Finding to Lead Optimization in Drug Discovery Under Flexible Business Models

Biomolecular Screening and ADMET services
View white paper
Reagents for Fine Organic Synthesis – Building Blocks Renowned for supply of quality screening compound libraries, Enamine, a globally operating medicinal chemistry driven CRO, has developed the world’s largest catalogue of in-house designed and synthesized Building Blocks to complement its large offering of products for early stage drug discovery projects. The company pioneered the Building Block market in the early 2000’s capitalizing on its increasing chemistry experience and the growing number of Building Blocks it had synthesized for library design and numerous synthesis programs.
View white paper
Pre-Packaged Diversity Sets of Compounds for Screening Built on pharmacological profile of compounds rather than on their chemical structure Pharmacological Diversity Set is a brand new tool for HTS campaigns.
View white paper
Collection of Compounds for High-Throughput Screening Enamine’s collection of 1.8 million screening compounds is the world’s largest and most reputable source of small molecules for drug discovery. The majority of the compounds have been synthesized in-house within last 10 years. Each year ca. 200,000 new compounds are added to our collection making it always fresh and interesting for the search of new leads.
View white paper
In-Stock-Tomorrow Tangible Structures – REAL Database REAL DataBase (RDB) is the array of 16 million feasible diverse drug-like structures. The compounds are synthesized in only 1 step using thoroughly protocolled chemical procedures from available building blocks.
View white paper
Library of Compounds for Fragment-Based Drug Design The fragment-based approach to drug discovery (FBDD) has been established as an efficient tool in the search for new drugs.1,2 It has been often used since the late 1990s.3 Nowadays a few compounds discovered by FBDD are entering the clinic.4 FBDD has emerged as an alternative approach to traditional lead identification via high-throughput screening (HTS).
View white paper
Pharmacological Diversity Set and 3D Diversity Set Three-dimensional shape is an essential property of molecules determining their principal ability to bind to biological targets. To maximize biological relevance of a compound library we sought to use this fundamental property in combination with other design approaches.
View white paper